Chemed (CHE) Other Non-Current Liabilities (2009 - 2026)

Chemed (CHE) has reported Other Non-Current Liabilities for 18 consecutive years, with $13.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 3.61% year-over-year to $13.5 million; the TTM figure through Mar 2026 stood at $13.5 million (up 3.61% YoY), while the FY2025 annual figure was $13.3 million, changed 0.25% from the prior year.
• Other Non-Current Liabilities came in at $13.5 million for Q1 2026 at Chemed, up from $13.3 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $13.5 million in Q1 2026, with the low at $10.3 million in Q1 2022.
• Average Other Non-Current Liabilities over 5 years is $12.7 million, with a median of $13.0 million recorded in 2024.
• The largest YoY upside for Other Non-Current Liabilities was 25.87% in 2022 against a maximum downside of 61.35% in 2022.
• Year by year, Other Non-Current Liabilities stood at $12.1 million in 2022, then advanced by 7.14% to $13.0 million in 2023, then climbed by 2.81% to $13.4 million in 2024, then retreated by 0.25% to $13.3 million in 2025, then grew by 1.41% to $13.5 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $13.5 million, $13.3 million, and $13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.